Biotech entity

Cetera Investment Advisers

Company

Every one of those 1 sits in a single category, pharma. CIBC Private Wealth Group LLC is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Cetera Investment Advisers, all published on August 16, 2026.

Last mentioned: Aug 16, 2026

Entity pulse

Recent coverage · Cetera Investment Advisers

1 story
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Cetera Investment Advisers

Every one of those 1 sits in a single category, pharma. CIBC Private Wealth Group LLC is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Biotech story that mention Cetera Investment Advisers, all published on August 16, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 7 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Cetera Investment Advisers. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Quarterly earnings release

    Lantern Pharma reported quarterly EPS of ($0.57), missing consensus by $0.19; shares rose $0.02 to $2.65.

  2. Weiss Ratings upgrade

    Weiss Ratings upgraded Lantern Pharma from 'sell (e+)' to 'sell (d-)'.

  3. Wall Street Zen rating action

    Research note on LTRN reported with conflicting direction across sources (upgrade to hold vs downgrade to sell).

Stories mentioning Cetera Investment Advisers 1

Cetera Investment Advisers is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.